SearcharxivSearch

arXiv subjects

Sara Amato

Publications and source records attributed to Sara Amato.

3 recordsLinked to original sources

Data-driven modeling and prediction of microglial cell dynamics in the ischemic penumbra

Neuroinflammation immediately follows the onset of ischemic stroke. During this process, microglial cells are activated in and recruited to the tissue surrounding the irreversibly injured infarct core, referred to as the penumbra. Microglial cells can be activated into two distinct phenotypes; however, the dynamics between the detrimental M1 phenotype and beneficial M2 phenotype are not fully understood. Using phenotype-specific cell count data obtained from experimental studies on middle cerebral artery occlusion-induced stroke in mice, we employ sparsity-promoting system identification techniques combined with Bayesian statistical methods for uncertainty quantification to generate continuous and discrete-time predictive models of the M1 and M2 microglial cell dynamics. The resulting data-driven models include constant and linear terms but do not include nonlinear interactions between the cells. Results emphasize an initial M2 dominance followed by a takeover of M1 cells, capture potential long-term dynamics of microglial cells, and suggest a persistent inflammatory response.

q-bio.CB

A data-informed mathematical model of microglial cell dynamics during ischemic stroke in the middle cerebral artery

Neuroinflammation immediately follows the onset of ischemic stroke in the middle cerebral artery. During this process, microglial cells are activated in and recruited to the penumbra. Microglial cells can be activated into two different phenotypes: M1, which can worsen brain injury; or M2, which can aid in long-term recovery. In this study, we contribute a summary of experimental data on microglial cell counts in the penumbra following ischemic stroke induced by middle cerebral artery occlusion (MCAO) in mice and compile available data sets into a single set suitable for time series analysis. Further, we formulate a mathematical model of microglial cells in the penumbra during ischemic stroke due to MCAO. Through use of global sensitivity analysis and Markov Chain Monte Carlo (MCMC)-based parameter estimation, we analyze the effects of the model parameters on the number of M1 and M2 cells in the penumbra and fit identifiable parameters to the compiled experimental data set. We utilize results from MCMC parameter estimation to ascertain uncertainty bounds and forward predictions for the number of M1 and M2 microglial cells over time. Results demonstrate the significance of parameters related to M1 and M2 activation on the number of M1 and M2 microglial cells. Simulations further suggest that potential outliers in the observed data may be omitted and forecast predictions suggest a lingering inflammatory response.

q-bio.CB

Modeling Microglia Activation and Inflammation-Based Neuroprotectant Strategies During Ischemic Stroke

Neural inflammation immediately follows the onset of ischemic stroke. During this process, microglial cells can be activated into two different phenotypes: the M1 phenotype, which can worsen brain injury by producing pro-inflammatory cytokines; or the M2 phenotype, which can aid in long term recovery by producing anti-inflammatory cytokines. In this study, we formulate a nonlinear system of differential equations to model the activation of microglia post-ischemic stroke, which includes bidirectional switching between the microglia phenotypes, as well as the interactions between these cells and the cytokines that they produce. Further, we explore neuroprotectant-based modeling strategies to suppress the activation of the detrimental M1 phenotype, while promoting activation of the beneficial M2 phenotype. Through use of global sensitivity techniques, we analyze the effects of the model parameters on the ratio of M1 to M2 microglia and the total number of activated microglial cells in the system over time. Results demonstrate the significance of bidirectional microglia phenotype switching on the ratio of M1 to M2 microglia, in both the absence and presence of neuroprotectant terms. Simulations further suggest that early inhibition of M1 activation and support of M2 activation leads to a decreased minimum ratio of M1 to M2 microglia and allows for a larger number of M2 than M1 cells for a longer time period.

q-bio.CB